Obstetrics & Gynecology Doctors in Clarksdale, MS Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Dr. Erica R Balthrop, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N State St, Clarksdale, MS 38614 Phone: 662-627-7361    Fax: 662-627-1158

Dr. Delphia M Hord, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N State St, Clarksdale, MS 38614 Phone: 662-627-7361    Fax: 662-627-1158

Dr. Kushna K Damallie, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N State St, Clarksdale, MS 38614 Phone: 662-627-7361    Fax: 662-627-1158

News Archive

Derma Sciences' MEDIHONEY HCS dressings receive CE Mark

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for the Company's patented MEDIHONEY HCS (hydrogel colloidal sheet) dressings.

Federal experts' advice on HPV vaccine could leave adults confused

Vaccination decisions are usually pretty straightforward. People either meet the criteria for the vaccine based on their age or other factors or they don't. But when a federal panel recently recommended an update to the human papillomavirus (HPV) vaccine guidelines, it left a lot of uncertainty.

30-day readmission rate does not accurately measure hospital quality

The 30-day window for hospital readmissions - used by the federal government to penalize hospitals believed to provide lower-quality care because patients return to the hospital following discharge - should be reduced to a week or less to more accurately measure factors within a hospital's control, new research from UC Davis has found.

Powerful clot-busting drugs found safe for treating stroke patients with dementia

Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain hemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports.

Shionogi Pharma presents data on PSD502 pivotal studies for primary premature ejaculation at 2010 AUA

Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., today presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation (PE). These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco.

Read more Medical News

› Verified 8 days ago